Cargando…
What should we expect when two myositis-specific antibodies coexist in a patient
BACKGROUND: The coexistence of two myositis-specific autoantibodies (MSA) is considered extremely rare. We describe three patients with both anti-signal recognition particle (SRP) antibodies and another MSA in serum. METHODS: We performed a retrospective clinical data collection and follow-up studie...
Autores principales: | Zheng, Yiming, Zhao, Yawen, Hao, Hongjun, Wang, Zhaoxia, Gao, Feng, Zhang, Wei, Yuan, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571367/ https://www.ncbi.nlm.nih.gov/pubmed/37828570 http://dx.doi.org/10.1186/s40001-023-01363-5 |
Ejemplares similares
-
Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies
por: Huang, Hung-Ling, et al.
Publicado: (2022) -
GMSB models: what should we expect at the LHC?
por: Ambrosanio, S
Publicado: (1998) -
Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010) -
Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023) -
Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody
por: Wang, Yikang, et al.
Publicado: (2023)